315 464-4243

Burk Jubelt, MD

CURRENT APPOINTMENTS

Professor Emeritus of Neurology

Professor of Microbiology and Immunology

Professor of Neuroscience Graduate Program

SPECIALTIES

Neurology

LANGUAGES

English

PATIENT TYPE

Adults

PATIENT RATING

4.8 / 5

CLINICAL BACKGROUND AND MY APPROACH TO CARE

Immune Response to CNS virus infections; Growth Factors for Post-Polio Syndrome; Immune-mediated diseases; Treatment of Multiple Sclerosis

DISEASES & CONDITIONS TREATED

Multiple Sclerosis (MS)

Post Polio Syndrome

CLINICAL LOCATIONS

Post-Polio Syndrome Research and Treatment Center

Upstate Health Care Center

Google Maps & Directions

90 Presidential Plaza

Syracuse, NY 13202

315 464-4243

CURRENT HOSPITAL PRIVILEGES

Upstate University Hospital

Crouse Hospital

VA Medical Center

CAMPUSES

Downtown

PREVIOUS APPOINTMENTS

Northwestern University Medical School, 1979-1989

PATIENT RATINGLearn more about ratings

Likelihood of patient recommending this care provider to others

4.8 / 5

Degree to which care provider talked with patient using words in clear and simple language

4.9 / 5

Explanations the care provider gave about patient problems or conditions

4.8 / 5

Concern the care provider showed for patient questions or worries

4.8 / 5

Care provider's efforts to include patient in decisions about treatment

4.8 / 5

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

0 / 5

PATIENT COMMENTS

August 16, 2018

excellent

July 9, 2018

I have been a patient of dr jubelt for over 10 years and have no complaints.

June 22, 2018

*Dr. Jubelt is the best. Not only is he a bright doctor he is also compassionate and treats people with respect.

December 11, 2017

I have no pain issues this visit. Dr Jubelt is the best as a provider and as a person. I am very fortunate he is my Neurologist.

December 5, 2017

Great doctor. I would totally recommend Dr. Jubelt. Great bedside manner.

November 14, 2017

good experience

October 10, 2017

DR JUBELT IS A GREAT PROVIDER WHO SPENDS TIME AND ANSWERS ANY CONCERNS THAT I HAVE

September 17, 2017

Again, Dr. Jubelt is a wonderful doctor. He is the only doctor I have have ever had such an open, trusting relationship. I dread the day I receive news he will retire.

August 29, 2017

Fortunately for me, I am not in any pain. Aside from some stiffness due to my MS, I'm in generally good health.

June 27, 2017

I asked to raise my medication & it was never done.

June 18, 2017

Dr. Jubelt is unique in his humility and in the thoughtfulness he extends toward his patients. Patients come from out of town to be treated by Dr Jubelt and I only wish he will never retire from treating MS patients. He has been my neurologist since 2003 when I was first diagnosed. I am so thankful that he is my doctor.

April 20, 2017

I feel fortunate to be a patient of *Dr. Jubelt's. He is extremely knowledgeable, thorough and never rushes.

WEB RESOURCES

Professional Site

RESEARCH PROGRAMS AND AFFILIATIONS

Neurology

Neuroscience Program

RESEARCH INTERESTS

CNS acute and chronic polio- and entero-virus infections; Growth factors for Post-Polio Syndrome; Treatment of Multiple Sclerosis; Amyotrophic Lateral Sclerosis (ALS) Motor Neuron Gene Expression

EDUCATION INTERESTS

How to take an accurate Neurological History; How to do an accurate Neurological Exam; MRI scans

ASSOCIATIONS / MEMBERSHIPS

American Academy of Neurology (AAN)

American Neurological Association

EDUCATION

Fellowship: Johns Hopkins University School of Medicine, 1979, Virology/Immunology

Residency: Presbyterian Hospital, Columbia University, 1976

MD: University of Kansas School of Medicine, 1972

RESEARCH ABSTRACT

Post-Polio Syndrome(PPS) in the Mouse. We have developed a model of PPS in the mouse in order to analyze pathogenesis and try different modalities of treatment. The growth factors GDNF and IGF1 have resulted in improved strength of the Post-Polio mouse.

Amyotrophic Lateral Sclerosis (ALS) Motor Neuron Gene Expression. Motor neurons have been isolated from autopsy spinal cords of ALS patients and controls. RNA has been isolated from these motor neurons and cDNA libraries have been constructed. Subtraction of these libraries has begun in an attempt to identify motor neuron specific genes and gene products.

Multiple Sclerosis Treatment. Mechanisms of action of present MS disease modifying agents. Development of new disease modifying agents.

References:

1. Christophi GP, Christophi JA, Gruber RC, Mihai C, Mejico LJ, Jubeltb. Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-B 1a treated multiple sclerosis patients. J Nourol Sci 2011; 307: 41-45.

2. Jubelt B, Mihai C, Li TM, Veerapaneni P. Rhombencephalitis / Brainstem Encephalitia. Curr Neurol Neurosci Rep 2011; 11:

3. Kister I et al. Rapid disaese course in African Americans with multiple sclerosis. Neurology 2010; 75: 217-223.

4. Jubelt B et al. Retrograde viral delivery of GDNF and IGF1 prevents the development of late weakness (Post-Polio Syndrome) in a mouse model. Neurology 2009 (suppl 3):A362.

HEALTHLINK ON AIR RADIO INTERVIEWS

2/27/13 Research study to develop a new medical treatment for multiple sclerosis (MS)

7/27/16 Syndrome can attack polio survivors years later